首页> 外国专利> TARGETED DELIVERY OF BOTULINUM TOXIN FOR TREATMENT AND PREVENTION OF TRIGEMINAL AUTONOMIC CEPHALALGIA, MIGRAINE AND VASCULAR CONDITION

TARGETED DELIVERY OF BOTULINUM TOXIN FOR TREATMENT AND PREVENTION OF TRIGEMINAL AUTONOMIC CEPHALALGIA, MIGRAINE AND VASCULAR CONDITION

机译:肉毒杆菌毒素的靶向输送,用于治疗和预防原发性自主神经性头痛,偏头痛和血管疾病

摘要

PROBLEM TO BE SOLVED: To treat and prevent migraine and other headaches associated with vascular disorders.SOLUTION: Botulinum toxin, among other presynaptic neurotoxins is used for the treatment and prevention of migraine and other headaches associated with vascular disorders. The presynaptic neurotoxins are delivered locally, targeting the nerve endings of the trigeminal nerve, the occipital nerve and the intranasal terminals of the parasympathetic fibers originating in the pterygopalatine ganglion. The administration preferably targets the extracranial nerve endings of the trigeminal nerve in the temporal area, the extracranial occipital nerve endings in the occipital area, and the intranasal terminals of the trigeminal nerve and parasympathetic fibers originating in the pterygopalatine ganglion. The delivery is carried out by way of injection or topically.
机译:解决的问题:治疗和预防偏头痛和其他与血管疾病有关的头痛。解决方案:肉毒杆菌毒素和其他突触前神经毒素可用于治疗和预防偏头痛和其他与血管疾病有关的头痛。突触前神经毒素在局部递送,靶向三叉神经,枕叶神经和源自翼pal神经节的副交感神经纤维的鼻内末端。该给药优选靶向颞区三叉神经的颅外神经末梢,枕叶区域的颅外枕神经末梢以及三叉神经的鼻内末端和源自翼pal神经节的副交感神经纤维。输送通过注射或局部进行。

著录项

  • 公开/公告号JP2012131826A

    专利类型

  • 公开/公告日2012-07-12

    原文格式PDF

  • 申请/专利权人 ALLERGAN INC;

    申请/专利号JP20120073935

  • 发明设计人 BLUMENFELD ANDREW M;

    申请日2012-03-28

  • 分类号A61K45;A61P25/06;A61P25/04;A61K38;A61K9/12;A61K9/08;

  • 国家 JP

  • 入库时间 2022-08-21 17:44:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号